<DOC>
	<DOC>NCT01325961</DOC>
	<brief_summary>The aim of the study is a medico-economic evaluation to estimate a cost differential between three modalities of Intensity-Modulated Radiation Therapy for cancers of the prostate, cervix and anal canal with pelvic lymph node irradiation : treatment with helical Tomotherapy and dynamic arc therapy using two different technologies: RapidArc or VMAT.</brief_summary>
	<brief_title>Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>WHO performance index â‰¤ 2 Age &gt; 18 years histologically proven carcinoma: Anal canal cancer locally advanced (&gt; 4 cm and / or N1 to N3) under irradiation on pelvic and inguinal lymph nodes with concurrent chemotherapy. The boost with brachytherapy are accepted Prostate cancer with pelvic lymph nodes and radiation or hormone therapy Cervical Cancer under a purely medical treatment involving irradiation on pelvic lymph nodes and primary tumor with concurrent chemotherapy without surgery. The Boost by external radiotherapy or brachytherapy are accepted. The investigator must ensure that the patient has not expressed its opposition to participate in this study. The signing of a consent form is optional; History of invasive cancer other than basal cell carcinomas. Indication of reirradiation paraaortic radiotherapy associated with pelvic irradiation. postoperative radiotherapy. geographical distance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>prostate, cervical and anal canal cancers with pelvic lymph node irradiation</keyword>
</DOC>